Treating Infectious Diseases: An Opportunity to Drive Global Health and Wealth
Humanity has struggled with infectious diseases and subsequent epidemics for centuries. The discovery of the first antibiotics in the early 20th century and the later
Humanity has struggled with infectious diseases and subsequent epidemics for centuries. The discovery of the first antibiotics in the early 20th century and the later
The COVID-19 pandemic has highlighted the vulnerabilities of societies and economies to infectious diseases and has given new importance to planning and preparedness for future
ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS